Harrow Health, Inc.HROWNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+37.7%
5Y CAGR+21.2%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+37.7%/yr
Annual compound
5Y CAGR
+21.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 13.99% | +26.2% |
| 2024 | 11.08% | +20.8% |
| 2023 | 9.18% | +71.2% |
| 2022 | 5.36% | -23.9% |
| 2021 | 7.04% | +31.5% |
| 2020 | 5.35% | +43.6% |
| 2019 | 3.73% | +145.7% |
| 2018 | -8.16% | +79.0% |
| 2017 | -38.84% | +45.4% |
| 2016 | -71.07% | - |